MitoSOXTM, a mitochondria-specific ROS indicator, was used to measure mitochondrial ROS levels, and the assay revealed that ROS levels were increased in AD-like skin lesion mice, but decreased in the IMP- and Rapa-treated AD-like skin lesion groups (Figure 4C). This evidence concerns the gene TRERF1 and Alzheimer disease.